GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Taiji Industry (Group) Co Ltd (SHSE:600129) » Definitions » Debt-to-Revenue

Chongqing Taiji Industry (Group) Co (SHSE:600129) Debt-to-Revenue : 0.46 (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Chongqing Taiji Industry (Group) Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Chongqing Taiji Industry (Group) Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥4,435 Mil. Chongqing Taiji Industry (Group) Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥353 Mil. Chongqing Taiji Industry (Group) Co's annualized Revenue for the quarter that ended in Sep. 2024 was ¥10,467 Mil. Chongqing Taiji Industry (Group) Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.46.


Chongqing Taiji Industry (Group) Co Debt-to-Revenue Historical Data

The historical data trend for Chongqing Taiji Industry (Group) Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Taiji Industry (Group) Co Debt-to-Revenue Chart

Chongqing Taiji Industry (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.49 0.39 0.32 0.27

Chongqing Taiji Industry (Group) Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.31 0.25 0.30 0.46

Competitive Comparison of Chongqing Taiji Industry (Group) Co's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Chongqing Taiji Industry (Group) Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chongqing Taiji Industry (Group) Co's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chongqing Taiji Industry (Group) Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Chongqing Taiji Industry (Group) Co's Debt-to-Revenue falls into.



Chongqing Taiji Industry (Group) Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Chongqing Taiji Industry (Group) Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3780.929 + 443.974) / 15622.648
=0.27

Chongqing Taiji Industry (Group) Co's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(4434.829 + 352.863) / 10466.612
=0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.


Chongqing Taiji Industry (Group) Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Chongqing Taiji Industry (Group) Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Taiji Industry (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Hengshan East Road, Yubei District, Chongqing, CHN, 401123
Chongqing Taiji Industry (Group) Co Ltd is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
Executives
Zhu Ming Xi Director
Xu Wei Guo Supervisors

Chongqing Taiji Industry (Group) Co Headlines

No Headlines